Xcyte Therapeutics entered the industry of Biologicals and Allied Products in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 5416140, which describes it as a Biologicals and Allied Products. For further clarification, the SIC classifies this business under the code 5122 and described it as a Biologicals and Allied Products. The business provides service to the BOTH market.
To acquire more information, please contact Ron Berenson by calling (206) 262-6200 during business hours. You can also write to the business’ Single Location at 1124 Columbia St, Seattle, Washington WA 98104. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Xcyte Therapeutics |
Representative: | Ron Berenson |
Place of Business: | 1124 Columbia St, Seattle, WA 98104 |
Contact Number: | (206) 262-6200 |
Type of Service: | Biologicals and Allied Products |
SIC Number: | 5122 |
NAICS Number: | 5416140 |
Locality: | Single Location |
Market Type: | B2B & B2C |
Began: | 2007 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Xcyte Therapeutics is a company operating from King, Washington providing professional Biologicals and Allied Products and relevant BOTH variables. It was founded in 2007 and registered with the SIC code 5122 as Biologicals and Allied Products, and with the NAICS code 5416140 as Biologicals and Allied Products.
With a current employee count of 1 to 4, Xcyte Therapeutics has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Ron Berenson at (206) 262-6200 for related queries, or to locate its Single Location using the coordinates 47.60818,-122.32332.
The Single Location can also be found at the street address 1124 Columbia St in Seattle, Washington 98104 and can be engaged online through the company website at , the company Twitter , and Facebook page .